Form 144 Hims & Hers Health, Inc. Filed by: Boughton Soleil
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Hims and Hers (HIMS) PT Lowered to $18 at Jefferies
August 7, 2024 10:16 AM EDTJefferies analyst Glen Santangelo lowered the price target on Hims and Hers (NYSE: HIMS) to $18.00 (from $23.00) while maintaining a Hold rating.
The analyst comments "We are updating our model following 2Q results and management's initial commentary on GLP-1s. We are raising our revenue... More
Hims and Hers (HIMS) PT Raised to $23 at Deutsche Bank
August 6, 2024 4:22 PM EDTDeutsche Bank analyst George Hill raised the price target on Hims and Hers (NYSE: HIMS) to $23.00 (from $16.00) while maintaining a Hold rating.
The analyst comments "Positioned to Grow Specialty Platform: HIMS reported a Q2 beat on a broad basis AMC on Monday where the GLP-1 opportunity in the near term was the overwhelming focus of the earnings call. Since the company... More
